chr4-40349021-T-C
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_017581.4(CHRNA9):āc.505T>Cā(p.Cys169Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000107 in 1,614,196 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_017581.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CHRNA9 | NM_017581.4 | c.505T>C | p.Cys169Arg | missense_variant | 4/5 | ENST00000310169.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CHRNA9 | ENST00000310169.3 | c.505T>C | p.Cys169Arg | missense_variant | 4/5 | 1 | NM_017581.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152204Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000111 AC: 28AN: 251412Hom.: 0 AF XY: 0.000103 AC XY: 14AN XY: 135868
GnomAD4 exome AF: 0.000113 AC: 165AN: 1461874Hom.: 0 Cov.: 31 AF XY: 0.000118 AC XY: 86AN XY: 727242
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152322Hom.: 0 Cov.: 32 AF XY: 0.0000805 AC XY: 6AN XY: 74488
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 16, 2021 | The c.505T>C (p.C169R) alteration is located in exon 4 (coding exon 4) of the CHRNA9 gene. This alteration results from a T to C substitution at nucleotide position 505, causing the cysteine (C) at amino acid position 169 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at